Welcome international healthcare professionals

Welcome, this website is intended for healthcare professionals with an interest in the ECC Webcasts. By clicking the button below you are declaring and confirming that you are a healthcare professional.

You are here

Welcome and Introduction

M. De Santis (United Kingdom)

SlotX-1

Maria De Santis introduces the Symposium, which covers how experts manage patients with metastatic castrate resistant prostate cancer, and raises the remaining unanswered questions that require more data and research.

Transcription

Learning Objectives

The learning objectives of this symposium is to learn how patients with metastatic castrate resistant prostate cancer are managed by experts in the field and to understand the remaining unanswered questions that require more data and research.

Full transcription

Full transcription

Learning Objectives

The learning objectives of this symposium is to learn how patients with metastatic castrate resistant prostate cancer are managed by experts in the field and to understand the remaining unanswered questions that require more data and research.

Symposium Faculty

Now I would like to introduce to you today’s faculty, esteemed colleagues and experts in the field; Neal Shore from the US, Christopher Parker from the UK and Francis Sundram, also from the UK.

They will present cases to you and give lectures to you within the next 90 minutes.

Agenda

This is the agenda and I will start with a little introduction and an overview for you.

Slide

To start with, however, we are interested in who are you and I would like you to use again your voting devices. 

E-voting question 

We are interested in knowing what is your speciality?  Please start voting now.  Are you a urologist, a medical oncologist, are you working in nuclear medicine, radiation oncology, are you a scientist, a nurse or other?

Please start voting.  [Pause for voting]

Not unexpectedly, medical oncology is leading and the others, who knows who they are?  Maybe pharma.

E-voting question

Another question for you; what is your main clinical interest?  Are you in general oncology, genitourinary oncology, prostate cancer only, clinical research or other?  Please vote.  [Pause for voting]

Okay, general oncology and I think this is a very good sign to have general oncologists being interested in prostate cancer and we have indeed exciting times.